MANNKIND CORP Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net
MANNKIND CORP (MNKD) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet · last filed 2016-03-15
- MANNKIND CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2015-12-31 was $0.00.
- MANNKIND CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2015-09-30 was $0.00.
- MANNKIND CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2015-06-30 was $0.00.
- MANNKIND CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2015-03-31 was $0.00.
- MANNKIND CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for fiscal 2015 was $0.00.
- MANNKIND CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for fiscal 2014 was $0.00.
- MANNKIND CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for fiscal 2013 was $0.00.
- MANNKIND CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for fiscal 2012 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |